Inactivation of sacB Gene Allows Higher 2,3-Butanediol Production by Bacillus licheniformis from Inulin
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252211983 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Emanoel Gergov und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Inulin, Butylene Glycols, Bacillus licheniformis, Fermentation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Operational Programme "Sci-ence аnd Education for Smart Growth" 2014-2020, co-funded by the EU from European Regional Development Fund, Operational Programme “Science and Education for Smart Growth” 2014–2020, EU from European Regional Development Fund.
Abstract (Originalsprache)
Bacillus licheniformis 24 (BL24) is an efficient, non-pathogenic producer of 2,3-butanediol (2,3-BD). However, during inulin fermentation, the strain produces large amounts of exopolysaccharides (EPS), which interfere with the process’ performance. The present study aims to investigate the effect that inactivation of the sacB gene, encoding levansucrase in BL24, has on 2,3-BD production efficiency. Knockout of the sacB gene was accomplished via insertional inactivation. The sacB-knockout variant formed 0.57 g/L EPS from sucrose and 0.7–0.8 g/L EPS from glucose and fructose, a 15- and 2.5-fold reduction relative to the wild type, respectively. Likewise, during batch fermentation with soluble inulin Frutafit® CLR, the mutant BLΔsacB produced significantly less EPS than the wild type, allowing the maintenance of pH at values favoring 2,3-BD synthesis. At pH 6.50, BLΔsacB reached a record titer of 128.7 g/L 2,3-BD, with productivity of 1.65 g/L/h, and a yield of 85.8% of the theoretical maximum. The obtained concentration of 2,3-BD is two-fold higher compared to that of the wild type. Subsequent RT-qPCR assays confirmed a successful sacB knockout. Three of the genes involved in inulin hydrolysis (sacA, sacC, and fruA) maintained their expression levels compared to the wild type, while that of levB increased. Although total EPS accumulation could not be completely eliminated via sacB gene knockout alone, the overall reduction in EPS content has enabled the highest yield of 2,3-BD from inulin to date, a promising result for the industrial production from inulin-rich substrates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
- Institute of Chemical Engineering, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
ORCID-Profile: Penka Petrova, Alexander Arsov, Lidia Tsigoriyna, Nadya Armenova, Kaloyan Petrov
Förderung
- Operational Programme "Sci-ence аnd Education for Smart Growth" 2014-2020, co-funded by the EU from European Regional Development Fund
- Operational Programme “Science and Education for Smart Growth” 2014–2020
- EU from European Regional Development Fund
Zitieren
APA
Gergov, E., Petrova, P., Arsov, A., Ignatova, I., Tsigoriyna, L., Armenova, N., & Petrov, K. (2024). Inactivation of sacB Gene Allows Higher 2,3-Butanediol Production by Bacillus licheniformis from Inulin. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252211983
Vancouver
Gergov E, Petrova P, Arsov A, Ignatova I, Tsigoriyna L, Armenova N, et al. Inactivation of sacB Gene Allows Higher 2,3-Butanediol Production by Bacillus licheniformis from Inulin. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252211983
BibTeX
@article{Gergov2024,
author = {Gergov, Emanoel and Petrova, Penka and Arsov, Alexander and Ignatova, Ina and Tsigoriyna, Lidia and Armenova, Nadya and Petrov, Kaloyan},
title = {Inactivation of sacB Gene Allows Higher 2,3-Butanediol Production by Bacillus licheniformis from Inulin},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252211983}
}
EUVIMED